Market Overview

What Caused The Opening Gap In Intra-Cellular Therapies?


Developer of treatments for neuropsychiatric and neurologic disorders, Intra-Cellular Therapies (NYSE: ITCI) today had a large opening gap of -22.59%.

Photo taken from the Opening Gap Signals tool inside Benzinga Pro.

Why Is ITCI Moving?

Intra-Cellular Therapies shares are trading lower after the company said its 401 Study of Lumateperone did not meet its primary endpoint.

Photo taken from the ‘Why Is It Moving?’ Details tool inside Benzinga Pro.

For live updates on ITCI, log in or try Benzinga Pro today.

Posted-In: Why is it movingNews Movers Trading Ideas


Related Articles (ITCI)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at